The activity of N-acetyl-beta-glucosaminidase and its isoenzymes in the renal tissue, serum and urine of patients with renal cancer = Aktywność N-acetylo-beta-heksozoaminidazy i jej izoenzymów w tkance nerki, w surowicy i w moczu pacjentów z rakiem nerki.

Renal cancer makes up around 3-4% of human neoplasms. It may metastasise, infiltrate and colonise other tissues. Infiltration and metastasis may depend on changes in the oligosaccharide structures of glycoconjugates of the glycocalyx, basement membranes and extracellular matrix. Oligosaccharides are degraded by endo- and exoglycosidases. N-acetyl-β-glucosaminidase (NAG) produced mainly by the epithelial cells of proximal convoluted renal tubules, is the most active of all exoglycosidases. N-acetyl-β-hexosaminidase is a lysosomal exoglycosidase which hydrolyses β-glycosides of N-acetylglucosamine (GlcNAc) and N-acetylgalactosamine (GalNAc) from glycoconjugates. In human tissues it exists as two major isoenzymes: a thermolabile NAG A and thermostabile NAG B. NAG is a glycoprotein composed of two subunits α and β. Isoenzyme A has composition αβ, isoenzyme B ββ, respectively. Genes coding subunit α NAG are localised to chromosome 15, and those coding subunit β are localised to chromosome 5. The cancerous tissue revealed a significantly lower activity, of NAG and its isoenzyme A, and transitional tissue showed an intermediate activity in comparison to control renal tissue. A significant increase in NAG activity was observed in the serum and urine of renal cancer patients, in comparison to control subjects. In conclusion we propose determination of NAG in urine as a potential marker of renal cancer.

[1]  H. Kanetake,et al.  Expression of metalloproteinase-2, metalloproteinase-9, and tissue inhibitor of metalloproteinase-1 in transitional cell carcinoma of upper urinary tract: correlation with tumor stage and survival. , 2004, Urology.

[2]  K. Zwierz,et al.  [Endoglycosidases and glycoamidases]. , 2004, Postepy biochemii.

[3]  J. López-Guerrero,et al.  Disruption of basement membrane, extracellular matrix metalloproteinases and E-cadherin in renal-cell carcinoma. , 2003, Anticancer research.

[4]  T. Kishimoto,et al.  Increased in situ gelatinolytic activity in renal cell tumor tissues correlates with tumor size, grade and vessel invasion , 2003, International journal of cancer.

[5]  O. Ishiko,et al.  Expression of matrix metalloproteinases 7 and 2 in human renal cell carcinoma. , 2003, Oncology reports.

[6]  M. Nishikido,et al.  Expression of cyclooxygenase-2 in renal cell carcinoma: correlation with tumor cell proliferation, apoptosis, angiogenesis, expression of matrix metalloproteinase-2, and survival. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[7]  A. Novick,et al.  Matrix metalloproteinase activity in urine of patients with renal cell carcinoma leads to degradation of extracellular matrix proteins: possible use as a screening assay. , 2003, The Journal of urology.

[8]  K. Zwierz,et al.  Isoenzymes of N-acetyl-beta-hexosaminidase. , 1999, Acta biochimica Polonica.

[9]  H. Roels,et al.  Association between NAG-B and cadmium in urine with no evidence of a threshold. , 1995, Occupational and environmental medicine.

[10]  K. Zwierz,et al.  [Beta-N-acetyl-hexosaminidase--the enzyme of Tay-Sachs and Sandhoff diseases]. , 1992, Postepy biochemii.

[11]  J. Barlow,et al.  Beta‐hexosaminidase activities and isoenzymes in normal human ovary and ovarian adenocarcinoma , 1982, Cancer.

[12]  K. Zwierz,et al.  The degradation of glycoconjugates in the human gastric mucous membrane. , 1981, Acta medica Academiae Scientiarum Hungaricae.

[13]  T. P. Pretlow,et al.  Cell fractionation of large bowel cancer , 1977, Cancer.

[14]  Y. S. Kim,et al.  Alterations of membrane glycopeptides in human colonic adenocarcinoma. , 1974, Proceedings of the National Academy of Sciences of the United States of America.